Literature DB >> 9599354

The Schwartz Cancer Fatigue Scale: testing reliability and validity.

A L Schwartz1.   

Abstract

PURPOSE/
OBJECTIVES: To describe the psychometric development of the Schwartz Cancer Fatigue Scale (SCFS).
DESIGN: A multiphase instrumentation study describing construct and operational definitions, informal and formal content validity, reliability, and validity analysis. SAMPLE: Content validity established with 20 subjects. Reliability and validity evaluated with 166 subjects residing in diverse parts of the United States.
FINDINGS: Eleven items that failed to show variance, had high interitem correlations, or failed to discriminate were eliminated. Factor analysis resulted in a four-factor solution that accounted for 70% of the variance. Cronbach's alpha for the total scale was estimated to be 0.96 and to be between 0.82 and 0.93 for the subscales.
CONCLUSIONS: The 28-item SCFS has demonstrated reliability and content and construct validity. Factor analysis supports the four subscales (physical, emotional, cognitive, and temporal). Preliminary construct validity has been demonstrated by differences in fatigue between those people who are currently receiving treatment and those who have completed treatment and by scores on a visual analogue scale of fatigue. IMPLICATIONS FOR NURSING PRACTICE: The SCFS may prove to be clinically relevant in assessing the effect of interventions to treat and manage cancer-related fatigue.

Entities:  

Mesh:

Year:  1998        PMID: 9599354

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  29 in total

1.  Fatigue in the Danish general population. Influence of sociodemographic factors and disease.

Authors:  T Watt; M Groenvold; J B Bjorner; V Noerholm; N A Rasmussen; P Bech
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

Review 2.  ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials.

Authors:  Andrea M Barsevick; Charles S Cleeland; Donald C Manning; Ann M O'Mara; Bryce B Reeve; Jane A Scott; Jeff A Sloan
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

3.  Qualities of fatigue and associated chronic conditions among older adults.

Authors:  Susan E Hardy; Stephanie A Studenski
Journal:  J Pain Symptom Manage       Date:  2010-06       Impact factor: 3.612

4.  The situational fatigue scale: a different approach to measuring fatigue.

Authors:  Chien-Ming Yang; Chih-Hsing Wu
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

5.  Advancing the biobehavioral research of fatigue with genetics and genomics.

Authors:  Debra E Lyon; Nancy L McCain; Rita H Pickler; Cindy Munro; R K Elswick
Journal:  J Nurs Scholarsh       Date:  2011-07-29       Impact factor: 3.176

6.  Energy, fatigue, or both? A bifactor modeling approach to the conceptualization and measurement of vitality.

Authors:  Nina Deng; Rick Guyer; John E Ware
Journal:  Qual Life Res       Date:  2014-11-02       Impact factor: 4.147

7.  Fatigue mediates the effects of exercise on quality of life.

Authors:  A L Schwartz
Journal:  Qual Life Res       Date:  1999-09       Impact factor: 4.147

8.  A randomised controlled trial comparing the effects of a 12-week supervised exercise versus usual care on outcomes in haematological cancer patients.

Authors:  Bonnie J Furzer; Timothy R Ackland; Karen E Wallman; Anna S Petterson; Sandy M Gordon; Kemi E Wright; David J L Joske
Journal:  Support Care Cancer       Date:  2015-09-30       Impact factor: 3.603

9.  The effect of resistance training on muscle strength and physical function in older, postmenopausal breast cancer survivors: a randomized controlled trial.

Authors:  Kerri M Winters-Stone; Jessica Dobek; Jill A Bennett; Lillian M Nail; Michael C Leo; Anna Schwartz
Journal:  J Cancer Surviv       Date:  2011-12-23       Impact factor: 4.442

10.  Factors predicting fatigue in breast cancer patients.

Authors:  Shahpar Haghighat; Mohammad Esmail Akbari; Kourosh Holakouei; Abbas Rahimi; Ali Montazeri
Journal:  Support Care Cancer       Date:  2003-05-03       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.